Sunrise Signs 5,000-Ton Anode Material Supply Contract With Pylontech, Expanding Into the European Residential Energy Storage Market GlobeNewswire December 05, 2025 DOVER, USA, Dec. 05, 2025 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) (“Sunrise” or the “Company”) today announced that its subsidiary, Sunrise (Guizhou) New Energy Materials Co., Ltd., has signed an […]

AllianceBernstein Global High Income Fund, Inc. (NYSE: AWF), a closed‑end management investment company, declared on this date, December 5, 2025, a one-time special income distribution of $0.0488 per share of Common Stock. The total distribution of $0.0488 is payable on January 16, 2026 to stockholders of record at the close of business on December 18,

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS” or “ADSs”) of WPP plc (NYSE: WPP) between February 27, 2025 and July 8, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. So what: If you purchased WPP plc ADSsduring

Nassau, The Bahamas, Dec. 05, 2025 (GLOBE NEWSWIRE) — Bahamasair and Emirates have now moved their interline agreement from planning to operation, enabling travellers from Emirates' global network to connect through Florida to the islands of The Bahamas. Passengers can book their entire journey on a single ticket, with coordinated baggage check-through across both airlines,

(NASDAQ:TSHA), DALLAS, Dec. 05, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on December 3, 2025, the Compensation Committee of Taysha's Board of Directors

(NasdaqGM:VERA), BRISBANE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on December 2, 2025, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 42,000 shares of Class A common stock and restricted stock units (RSUs) underlying

(NASDAQ:MHUA), Yangzhou, China, Dec. 05, 2025 (GLOBE NEWSWIRE) — Meihua International Medical Technologies Co., Ltd. (“Meihua” or the “Company”) (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, announced today that the Company received a letter from the Nasdaq Stock Market LLC (“Nasdaq”)

(NASDAQ:PTHL), Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) — Pheton Holdings Ltd (NASDAQ: PTHL) (“Pheton” or the “Company”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the successful completion of its acquisition of 51% of the total outstanding shares of iTonic Corporation (the “Target”),

(NASDAQ:SYRE), WALTHAM, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease and rheumatic diseases, today announced that Spyre's independent Compensation Committee of the Board of Directors approved the

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 05, 2025 DALLAS, Dec. 05, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today